Copay Assistance – Good For Patients, Bad For Prices
Peter Bach and I have an essay in the Annals of Internal Medicine laying out some of the problems with pharmaceutical funded copay assistance programs. Check it out.
Peter Bach and I have an essay in the Annals of Internal Medicine laying out some of the problems with pharmaceutical funded copay assistance programs. Check it out.
Lots of us eat when we are stressed. But did you know that even when we are not currently under stress, the amount of food we eat might be influenced by the stress we experienced as children? That’s the conclusion Sarah Hill, a psychologist at TCU, wants us to draw from several studies she ran…
Obamacare is a big, messy law with so many moving parts, it is often hard to tell how well it’s working. People debate whether it is killing jobs or creating them; they argue about whether it is lowering medical expenses or raising them. These debates often feel irresolvable because the law, being a national one,…
Imagine that you are gasping for breath, literally on the verge of death. Then someone injects you with a medicine and – miracle! – you are perfectly healthy again. Would you pay $300 for that injection? The treatment is epinephrine; your illness was a life-threatening allergy. And that $300 price? That reflects a six-fold increase…
Among people receiving hospice care, the last few days of life can be intense, with progression of pain or breathing problems or other symptoms of their terminal illnesses. For those who die on Sundays, that means they are less likely to see doctors or nurses in the last days of life:
Want to go bankrupt from medical bills? You should move to the United States, where that fate is WAY more possible than in other wealthy countries: #WeNeedToFixThis
Research led by Stacey McMorrow (a former student of mine) shows that Obamacare was especially helpful in enabling black and Hispanic people obtain healthcare insurance: Disparities in insurance rates among either groups are declining: